Andy Cloyd’s Post

I couldn’t be more excited to team up with 10X Health. A company whose sole mission is to help people LOVE the way they feel. One of the first steps is discovering why you are feeling the way you are. Let’s figure out your body’s nutrient deficiencies with the 10X Genetic Test. One test that will show you exactly how your genes operate, what areas need improvement, and a roadmap on how to optimize it. Check out this link to get started: GENETIC TEST https://lnkd.in/gtnAPicG SUPPLEMENTS https://lnkd.in/g-_dQdkq SUPER HUMAN PROTOCOL https://lnkd.in/gFxKi7UW #unclenicskitchen

FOOD FOR THOUGHT: Having spent a good amount of time over the last six months wrapping my head around the Food as Medicine (FAM) and Medically Tailored Meals (MTM) trend, here’s what I learned: * Based on a 2022 study, 68.8% of participants had Diabetes, mostly Type 2. * 70.6% had been diagnosed with cardiovascular disease, a close correlation, well known as the number one chronic disease killer in the U.S. After almost 4 years in the cancer metabolism space, formulating high quality meals to boost the effectiveness of conventional therapy, it’s time for a change.  Clearly there is a need for chef driven, high quality, nutrient dense, disease reversing, clean label food related to the “biggies”, diabetes and cardiovascular. AS A RESEARCH CHEF AND PRECISION NUTRITION MEAL DEVELOPER FOCUSED ON LOW GLYCEMIC, THIS IS WHERE I PLAN TO HANG MY HAT FOR THE NEXT FEW YEARS. 👨🍳 Stay tuned for more.

Integrating Nutrigenomics into Clinical Practice: A Step Toward Personalized Medicine 🧬🍏 As we advance in the field of genomics, the integration of nutrigenomics into clinical practice is becoming increasingly feasible and beneficial. Nutrigenomics—the study of how genes and nutrition interact—holds the potential to revolutionize personalized healthcare by tailoring dietary recommendations based on individual genetic profiles. 🌟 Recent studies highlight that understanding a patient’s genetic makeup can lead to more precise and effective dietary interventions. For example, genetic testing can reveal variations in genes related to nutrient metabolism, allowing clinicians to provide personalized advice that optimizes health outcomes and minimizes risks associated with conditions such as obesity, cardiovascular disease, and diabetes (Kapsokefalou et al., 2023). 🧬📊 Incorporating nutrigenomics into clinical practice involves several key steps: Genetic Testing: Utilizing genetic tests to assess variations that affect nutrient metabolism and dietary needs. 🧪 Personalized Nutrition Plans: Developing tailored dietary recommendations based on genetic insights. 🍽️ Continuous Monitoring: Regularly reviewing and adjusting nutritional plans based on patient progress and emerging research. 🔍 The benefits of this personalized approach are becoming evident, with improved patient adherence and more effective management of chronic conditions. As we move forward, it's crucial for healthcare providers to stay informed about the latest advancements and consider integrating these insights into their practice. 🚀 Let's embrace the future of personalized medicine and make strides toward a more precise approach to nutrition and health! 💡 #Nutrigenomics #PersonalizedMedicine #ClinicalPractice #Genomics #Healthcare

What always intrigues me is the perpetuation of the myth that food and concentrated nutrients from food (i.e. supplements) can't ever be useful for combating the unpleasantness of certain conditions - whether disease or part of the so-called "healthy" aging process. For some very vocal key opinion leaders (KOLs), it seems that no matter how many large randomized control trials (RCTs) are done and the accumulating supporting science there, no amount of evidence will appease them. When it comes to supplements, for them, "the science is still out" or "the trials are not of sufficient quality", "the funding source is questionable" or even "the RCT should be multicenter".  These are valid points, and yet... I know for some of those KOLS, they sometimes grudgingly admit that their stance is largely because their fear is that if they publicly admit there could be any benefit to a particular food/nutrition approach, people may seek salvation in a supplements-only regimen and miss out on life-saving conventional therapy (drugs, surgery, and/or medical device intervention). I think we need to tackle these nuanced discussions now more than ever.

⚜️ Unlock the Power of Chromium: A Strategic Approach for Healthcare Professionals ⚜️ Chromium is a crucial trace element with significant implications in managing metabolic health, particularly in diabetes care and weight management. For pharmacists and healthcare providers, understanding its clinical potential is essential in delivering superior patient outcomes. 🟡 Primary Sources: Whole Grains: Barley, oats, whole wheat Vegetables: Broccoli, potatoes Meats & Seafood: Beef, poultry, shellfish 🟢 Key Clinical Benefits: Optimized Glucose Control: Enhances insulin sensitivity, lowers fasting blood glucose—ideal for managing Type 2 diabetes. Weight Management: Stabilizes blood sugar levels, reducing cravings and supporting lean muscle mass. Cardiovascular Support: Improves lipid profiles by lowering LDL cholesterol and enhancing endothelial function. 📈 Boost Your Practice By integrating chromium into your patient care strategies, you can enhance treatment plans, drive better outcomes, and set a new standard in personalized healthcare. 👉 Read the full article for in-depth insights: ( https://lnkd.in/dNGSPC3E) #Chromium #PharmacyInnovation #HealthcareStrategy #DiabetesManagement #PharmacistLeadership #ClinicalExcellence #ChronicCare #HealthOptimization #PatientOutcomes #PharmacyPractice #StrategicHealthcare #PreventiveMedicine #PharmaceuticalCare #ProfessionalGrowth

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐧𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐜𝐚𝐧𝐜𝐞𝐫 𝐜𝐚𝐫𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟕.𝟏𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟒.𝟗% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝. 𝙈𝙤𝙧𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 𝘿𝙚𝙩𝙖𝙞𝙡𝙨: https://lnkd.in/dwcD-fdb   The ability of nutritional support products to improve the immunity of cancer patients by providing the required amount of nutrients is primarily responsible for the market growth. Moreover, the implementation of strategic initiatives such as new product launches, merges, acquisitions, alliance, and partnerships contribute to the market #growth. #clinicalnutrition #cancercare #nutritionandcancer #oncologynutrition #cancernutrition #clinicaldiet #nutritiontherapy #medicalnutrition #cancerpatients #healthyeating #nutritionsupport 

I am thrilled to announce that our recent study investigating “the additive value of nutritional deficiency to frailty index in assessing the risk of heart failure adverse events” has been published to “The Journal of Nutrition, Health and Aging.” In this study we evaluated the differences in predictive value of frailty index along with nutritional status compared to frailty index alone, for different adverse outcomes of veterans admitted with Heart Failure. By incorporating a large cohort of Veterans admitted due to heart failure, we found that adding prognostic nutritional index (PNI) to frailty index (FI) provides a more accurate and comprehensive assessment among this group of participants. Adding malnutrition to frailty screening can help to determine which patients hospitalized for HF exacerbations are at higher risk for adverse outcomes. Utilizing this screening tool early on during hospital admissions may help identify patients who need either earlier interventions or changes in medical management to prevent worse outcomes and prolonged hospitalizations. Thanks to the great team for this hard work. Javad Razjouyan, PhD, M Eng. Ariela Orkaby Erica Kim Molly Horstman Orna Intrator Aanand D. Naik, M.D. Catherine Park

Very excited about our two most recent publications, out now in eBioMedicine & PLOS Digital Health! Lots of data is collected as part of routine clinical care that may be a treasure trove for addressing chronobiological questions, but how do we tap into these given the biases & confounding that are present in these data? In the first publication, led by Floor Hiemstra, we show that glucose levels display marked 24-hour variation in patient in the Intensive Care Unit, even during the provision of continuous enteral nutrition. This daily variation persists after controlling for sources of potential bias that may be introduced by sample timing bias or administration of glucose-modulating therapies. Thanks to co-authors Dirk Jan Stenvers, Dries Kalsbeek, Evert De Jonge and David van westerloo for their support & input along the way! Check it out here: https://lnkd.in/gsvKFxNj In the second publication, together with Marc Ruben, Hassan S Dashti, Carsten Skarke, and Luísa Klaus Pilz, we discuss the opportunities and challenges around the use of routinely collected clinical data in circadian medicine. We also provide a list of recommendations for other researchers in this area. Check it out here: https://lnkd.in/gNXU-2pr    Leiden University Medical Center BioClock

In Cell Press: Rhythms of the Infant Gut Microbiome - A Clinical study #Mysummary In this randomized controlled trial involving 210 infants were randomly assigned to different formula groups (placebo, Bifidobacterium-supplemented, GOS-supplemented, or Bifidobacterium + GOS). 63 exclusively breastfed infants served as a reference group Dirk Haller et al,. found that the assembly of infant gut microbiota is primarily driven by age, with less influence from the diet (formula vs. breastfeeding). However, metabolite profiles substantially differed between formula-fed and breastfed infants. But the real surprise came when they discovered the presence of diurnal (24-hour) oscillations in the abundance of various bacterial taxa, including Bifidobacterium, Veillonella, Bacteroides, Streptococcus, and Clostridium, in both formula-fed and breastfed infants. Interestingly, the number of "rhythmic" bacterial taxa increased with age and was highest in infants fed formula supplemented with galacto-oligosaccharides (GOS) and Bifidobacterium, even surpassing that of breastfed infants. #Mythoughts Food for thought: How might the presence of intrinsic bacterial clock mechanisms influence our understanding of the development of circadian rhythms and their impact on health throughout the lifespan? HAPPY to hear your THOUGHTS and Stay POSITIVE! #Myinspiration “Anyone who stops learning is old.” Henry Ford Link to the paper here: https://lnkd.in/eJ3QY3Kg #microbiome #science #biology #health #pharma #diet #nutrition #probiotics #therapeutics #startup #biotech

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐧𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐜𝐚𝐧𝐜𝐞𝐫 𝐜𝐚𝐫𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟕.𝟏𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟒.𝟗% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝. 𝙈𝙤𝙧𝙚 𝙍𝙚𝙥𝙤𝙧𝙩 𝘿𝙚𝙩𝙖𝙞𝙡𝙨: https://lnkd.in/diT6Ayn3   The ability of nutritional support products to improve the immunity of cancer patients by providing the required amount of nutrients is primarily responsible for the market growth. Moreover, the implementation of strategic initiatives such as new product launches, merges, acquisitions, alliance, and partnerships contribute to the market hashtag#growth. #clinicalnutrition #cancercare #nutritionandcancer #oncologynutrition #cancernutrition #clinicaldiet #nutritiontherapy #medicalnutrition #cancerpatients #healthyeating #nutritionsupport #polaris Polaris Market Research & Consulting